XORTX Therapeutics (XRTX) Times Interest Earned (2020 - 2023)
XORTX Therapeutics (XRTX) posted Times Interest Earned of -$981.7 for Q1 2023, down 3347.4% on a QoQ basis from -$28.48 in Q4 2022, and up 9.49% year-over-year from -$896.58 in Q1 2022.
XORTX Therapeutics (XRTX) Times Interest Earned (2020 - 2023) Analysis & Trends
XORTX Therapeutics' Times Interest Earned history runs 4 years deep, the most recent figure standing at -$981.7 for Q1 2023.
- Quarterly Times Interest Earned rose 9.49% year-over-year to -$981.7 in Q1 2023, while the trailing twelve-month figure through Mar 2026 was $1052142055.5 billion (up 140.12% YoY) and the FY2025 annual result came in at -$62.44, down 138.52% from the prior year.
- Times Interest Earned was -$981.7 for Q1 2023 at XORTX Therapeutics, down from -$28.48 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1302.4 in Q2 2021 and bottomed at -$1084.7 in Q1 2022.
- A 4-year average of $55.88 and a median of -$24.87 in 2022 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 87.71% in 2022, while the deepest fall reached 364.31% in 2022.
- XORTX Therapeutics' Times Interest Earned stood at $584.84 in 2020, then plunged by 139.63% to -$231.77 in 2021, then surged by 87.71% to -$28.48 in 2022, then plunged by 3347.4% to -$981.7 in 2023.
- Business Quant data shows XRTX's Times Interest Earned at -$981.7 in Q1 2023, -$28.48 in Q4 2022, and -$24.87 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | XORTX Therapeutics | 2.91 Bn | 2.91 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -981.70 |
| Dec 31, 2022 | -28.48 |
| Sep 30, 2022 | -24.87 |
| Jun 30, 2022 | -81.50 |
| Mar 31, 2022 | -1,084.69 |
| Dec 31, 2021 | -231.77 |
| Sep 30, 2021 | 293.96 |
| Jun 30, 2021 | 1,302.42 |
| Mar 31, 2021 | 410.38 |
| Dec 31, 2020 | 584.84 |
| Sep 30, 2020 | 456.11 |